PGE1 short term therapy in critical lower limb ischemia

International Angiology

Volumn 22, Issue 1, 2003, Pages 58-63

  Bandiera, G ^a  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

Alprostadil; Arteries occlusive diseases; Ischemia; Leg; Prostaglandins

Indexed keywords

ANALGESIC AGENT; PROSTAGLANDIN E1;

ABDOMINAL PAIN; ADULT; AGED; ANALGESIA; ARTHRALGIA; ARTICLE; BLOOD PRESSURE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; HYPOTENSION; INTERMITTENT CLAUDICATION; LEG ISCHEMIA; LENGTH OF STAY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MYALGIA; NAUSEA; PAIN ASSESSMENT; PERIPHERAL OCCLUSIVE ARTERY DISEASE; RASH; REVASCULARIZATION; SHORT COURSE THERAPY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SWEAT GLAND DISEASE; TACHYCARDIA; TREATMENT OUTCOME; VISUAL ANALOG SCALE; VOMITING; WOUND HEALING;

AGED; ALPROSTADIL; ARTERIAL OCCLUSIVE DISEASES; BLOOD FLOW VELOCITY; CASE-CONTROL STUDIES; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; ISCHEMIA; LEG; MALE; MIDDLE AGED; PAIN MEASUREMENT; PERIPHERAL VASCULAR DISEASES; TIME FACTORS; VASODILATOR AGENTS;

EID: 0037710258     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Weeks JR. Prostaglandins. Annu Rev Pharmacol 1972; 12: 317-36.
2. Moncada S, Vane JR. Arachidonic acid methabolism and the interactions between platelets and blood vessel walls. N Engl J Med 1979;300:1142-7.
3. Kahan RH, Lands WEM. Prostaglandins and cyclic AMP: biological actions and clinical applications. New York: Academic Press, Inc, 1973.
4. Adaikan PG, Kottegoda SR. Prostacyclin analogs. Correlates in pharmacostructures. Drugs of the Future 1985;9: 756-74.
5. Bergstrom S, Siovall J. The isolation of prostaglandin E1 from sheep prostate glands. Acta Med Scand 1960;14: 1701-5.
6. Balzer K, Bechra G, Bisler H, Diehm C, Valter P, Wolf S. Placebo-kontrollierte, doppel blinde Multicenterstudie zur Wirksamkeit von Iloprost bei der Behandlung ischamischer Ruheschmerzen von Patienten mit peripheren arteriellen Durchblutungssorungen. Vasa 1987; Suppl 20:379-81.
7. 2), mimetics in severe peripheral vascular disease. Biomed Biochim Acta 1988;47:10-1.
8. De Gaetano G, Bertelé V, Cerletti C. Mechanism of action and clinical use of prostanoids. In: Dormandy JA, Stock G, editors. Critical leg ischaemia. Its pathopysiology and management. Berlino-Heidelberg: Springer-Verlag; 1990.p.117-37.
9. 2 in peripheral arterial ischemia. J Vasc Surg 1986;2:370-4.
10. European Working Group on Critical Leg Ischemia. Second European consensus documente on chronic critical leg ischemia. Circulation 1991;84 Suppl IV:1-26.
11. Balzer K. Efficacy and tolerability of intra-arterial and intravenous prostaglandin E1 infusion in occlusive arterial disease stage III-IV. Vasa 1989; Suppl 28:31-7.
12. Norgren L, Alusnark A, Angquist KA, Bergquist D, Holm J, Ortenwall P. A stable prostacyclin analogue (iloprost) in the treatment of ischemic ulcers of the lower limb. A Scandinavian Polish placebo-controlled, randomised multicenter study. Eur J Vasc Surg 1990;4:463-7.
13. Heidrich H. Intravenous prostavasin therapy in peripheral arterial occlusive disease in Fontaine's stages III and IV. Early and late results of a screening study. Prostaglandins in Clinical Research: Cardiovascular System, Alan R. Liss Inc. 1989.p.411-6.
14. Diehm C, Stammler F, Hubsh-Muller C, Eckstein HH, Simini B. Clinical effects of intravenously administered prostaglandin E1 in patients with rest pain due to peripheral obliterative arterial disease (POAD). A preliminary report on a placebo-controlled double-blind study. Vasa 1987; Suppl 17:52-6.
15. Heidrich H. Long term intravenous infusion of PGE1 in peripheral arterial blood flow disorders: results of an open screening study with patients in Fontaine's stages III and IV. Berlin: Springer Verlag; 1986.p.92-8.
16. Trubestein G, Diehm C, Gruss JD, Horsh S. Prostaglandin E1 in chronic arterial disease. A multicentric study. Vasa 1987; Suppl 17:39-43.
17. Boehme H, Brulisauer M, Hartel U, Bollinger A. Kontrollierte Studie zur Wirksamkeit von i.a. Prostaglandin E1 Infusionen bei periferer arterieller Verschlusskrankheit im Stadium III und IV. Vasa 1987; Suppl 20:206-8.
18. Eklund AE, Eriksson G, Olsson AG. A controlled study showing significant short term effect of prostaglandin E1 in healing of ischaemic ulcers of the lower limb in man. Prostaglandins Leukot Med 1982;8:265-71.
19. Sakaguchi S, Kusaba A, Mishima Y, Nishimura A, Furukawa K, Sakuma A. A multi-clinical double blind study with PGE1 in patients with ischemic ulcer of the extremities. Vasa 1978;7:263-7.
20. Belch JJF, McKay A, McArdle BM, Lowe GD, Forbes CD, Prentice CR. Epoprostenol (prostacyclin) and severe arterial disease. A double-blind trial. Lancet 1983;1:315-7.
21. Wicklmair M. Terapia con prostaglandine, efficacia e nuovi meccanismi d'azione. 18th European Conference on Microcirculation: Tavola rotonda. Rome, 5 September 1994.
22. Balzer K, Rogatti W, Ruttgerodt K. Therapeutische Wirksamkeit von Prostaglandin E1 - intra-arterielle und intravenose PGE1-Therapie bei AVK im Stadium III/IV. Therapiewoche 1989;39:2736-42.